Assessment of uptake of cervical cancer screening services among women of reproductive age in Khwisero sub-county, Kakamega County, Kenya

James G. Kiboche, Philip A. Ogutu, Anne Naliaka Mustami


Background: Cervical cancer stands to be amongst the major contributors to cancer demises and morbidity in the world. It is also ranked fourth among the most frequent types of cancer among women. The objective was assessing uptake of services for cervical cancer screening amongst women in the reproductive age in Khwisero Sub County, Kakamega County, Kenya.

Methods: Cross sectional descriptive study of 393 females from the age of eighteen to forty nine who were purposively sampled from was conducted. A questionnaire was administered by the interviewer. The data was collected, cleaned and entered in the analysis software (SPSS version 17). The Pearson Chi-square was used to conduct bivariate analysis in order to define the relationships between the variables having a level of significance at p<0.05. The presentation of the captured results was then done in pie-charts, graphs, charts and tables.

Results: Of the 393 interviewed 16.8% had a cervical cancer screening done either through pap smear, VIA and VILI within the past year. Significant influencers of screening uptake were marriage, age, parity, and health providers’ support.

Conclusions: There was a low level of awareness and knowledge on cervical cancer which resulted in low uptake levels of screening services which also influenced by other factors like age and marital status.


Awareness level, Cervical cancer screening, Reproductive age, Uptake

Full Text:



WHO. (2018). Cervical Cancer. Geneva, Switzerland: World Health Organization. Available from: Accessed on 25 September 2020.

CDC. (2018). Cervical cancer epidemiology in the U.S. Atlanta, GA: Centers for Disease Control and Prevention. Available at: cancer/cervical/statistics/index.htm. Accessed on 25 September 2020.

Nmor TA. Alcohol Consumption and Cervical Cancer Associations Among Women in Los Angeles, California. Walden Dissertations and Doctoral Studies. 2018.

McGahan CE, Linn K, Guno P, Johnson H, Coldman AJ, Spinelli JJ, Caron NR. Cancer in First Nations people living in British Columbia, Canada: an analysis of incidence and survival from 1993 to 2010. Cancer Causes Control. 2017;28(10):1105-16.

Williams D, Brain K. Women's perspectives on human papillomavirus self‐sampling in the context of the UK cervical screening programme. Health Expect. 2017;20(5):1031-40.

Lim JN, Ojo AA. Barriers to utilisation of cervical cancer screening in Sub Sahara Africa: a systematic review. Eur J Cancer Care. 2017;26(1):12444.

Adewole IF, Edozien EC, Babarinsa IA, Akang EE. (2017).Invasive and in situ carcinoma of the cervix in young Nigerians. A clinicopathologic study of 27 cases. African J Med Med Sci. 2017;21(1):35-45.

Oguntayo OA, Zayyan M, Kolawole AO, Adewuyi SA, Ismail H, Koledade K. Cancer of the cervix in Zaria, Northern Nigeria. Ecancermedicalscience. 2011;5.

Pindiga UH, El-Nafaty AU, Ekanem IA. Female genital malignancies in Maiduguri, Nigeria: A review of 328 cases. Trop J Obstet Gynaecol. 1999;16:52-6.

Goldie SJ, Gaffiken L, Fierbert J, Tobar A. Cost efficiency of cervical cancer screening in 5 emerging nations. N Engl J Med. 2015;353:2158-68.

South African National Cause-of-Death Validation report. Available at: research-reports. Accessed on 25 September 2020.

Denny L, Quinn M, Sankaranarayanan R. Cervical cancer screening for in emerging nations. Vaccine. 2016;24:S71-7.

World Health Organization. National cancer control programmes: policies and managerial guidelines. World Health Organization. 2014. Available from: Accessed on 25 September 2020.

Zahedi L, Sizemore E, Malcolm S, Grossniklaus E, Nwosu O. Information, attitudes and practices regarding cervical cancer and screening among haitian health care workers. Univers J Environ Res Public Health. 2014;11:11541-52.

Mutuku O, Kavoi B, Kahato M. Prevalence of abnormal cerviceal cytology among women infected with HIV in Machakos County Hospital Kenya. East Afr Med J. 2017;94(8):607-14.

KCSNS. Cancer burden in Kenya: Cervical cancer. Nairobi, Kenya: Kenya Cancer Statistics and National Strategies. 2016. Available at: Accessed on 25 September 2020.

Plourde N, Brown H, Vigod S, Cobigo V. Contextual factors associated with uptake of breast and cervical cancer screening. Women Health. 2016;56(8):906-25.

Gebreegziabher M, Asefa NG, Berhe S. Factors affecting the practices of cervical cancer screening among female nurses at Public Health Institutions in Mekelle Town, Northern Ethiopia, 2014: a Cross-Sectional Study. J Cancer Res. 2016;2016.

Morris MR. Factors associated with the uptake of cervical cancer screening among women of reproductive age in Homabay County, Kenya: a case of Kanyadhiang sub location. Clin Mother Child Health. 2016;13(232):2.

Sabatino S, White M, Thompson T, Kabunde T. Cancer screening test use: United States. Morbid Mortal Week Rep. 2015;64(17):464-8.

KNBS. Kenya Demographic survey 2008-09. Nairobi, Kenya: Kenya National Bureau of Statistics. 2010. Available from: Accessed on 25 September 2020.

Kotrlik JW, Higgins CC. Organizational research: Determining appropriate sample size in survey research. Inform Tech Learn Perform J. 2001;19(1):43.

McCarthy S, Walmer K, Boggan J. Awareness of cervical cancer causes of pre-determinants of likelihood to screen among women in Haiti: understanding cervical screening. J Lower Genit Tract Dis. 2017;21(1):37.

Ebu N, Mupepi S, Siakwa M. Knowledge, practice and barriers toward cervical cancer screening in Elmina, Southern Ghana. Int J Women’s Health. 2015;7:31.

Chaudhuri S, Dutt R, Goswami S. Awareness about cervical cancer screening among reproductive-aged women attending gynecology outpatient department in ESIC medical college and Hospital, Joka, Kokata. Int J Community Med Public Health. 2017;4(4):1319-23.

Saqer A, Ghazal S, Barqawi H, Elmekresh MM. Knowledge and awareness about cervical cancer vaccine (HPV) among parents in Sharjah. Asian Pacific journal of cancer prevention: APJCP. 2017;18(5):1237.

Ncube B, Bey A, Knight J, Bessler P. Variables related to the take-up of Cervical malignant growth screening among ladies in Portland, Jamaica. North Am J Med Sci 2015;7(3):104.

Wong E, Chan P, Chor J, Cheung A. Evaluation of the impact of human papillomavirus DNA self-sampling on the uptake of cervical screening. Cancer Nurs. 2016;39(1).

Sankaranarayanan R, Bhatla N, Basu P. Current global status & impact of human papillomavirus vaccination: Implications for India. The Indian journal of medical research. 2016;144(2):169..

Jacobs E, Rathouz P, Karavalos K. Perceived discrimination is associated with reduced breast and cervical cancer screening: The study of Women’s Health Across the Nation (SWAN). J Women’s Health. 2014;23(2):138-45.

Hanske J, Trinh QD, Menon M, Nguyen P. The influence of marital status on the use of breast, cervical and colorectal cancer screening. Prevent Med. 2016;89:140-5.

Kileo N, Michael D, Neke N, Moshiro C. Usage of cervical malignancy screening administrations and its related variables among grade teachers in Ilala Municipality, Dar es Salaam, Tanzania. BMC Health Serv Res. 2015;15(1):552.